| GOLDMAN SACHS EMERGING MARKETS EX-CHINA EQUITY PORTFOLIO I SD GBP CAP | RVI EMERGENTES | 71,46% | 100,04% | · | · |
| FIDELITY FUNDS-ASIAN SPECIAL SITUATIONS Y-ACC-EUR | RVI ASIA EX-JAPÓN SMALL/MID CAP | 71,44% | 96,22% | 52,02% | · |
| BGF NEXT GENERATION TECHNOLOGY E2 EUR | RVI TECNOLOGÍA | 71,43% | 114,06% | 29,67% | · |
| FIDELITY FUNDS-ASIAN SPECIAL SITUATIONS I-ACC-USD | RVI ASIA EX-JAPÓN SMALL/MID CAP | 71,41% | 95,65% | 53,43% | · |
| RBC FUNDS (LUX)-ASIA EX-JAPAN EQUITY FUND A CAP USD | RVI ASIA EX-JAPÓN | 71,36% | 96,34% | 50,32% | 173,70% |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA EQUITY PORTFOLIO I SD EUR CAP | RVI EMERGENTES | 71,27% | 99,90% | · | · |
| UBS MSCI EM EX CHINA SOCIALLY RESPONSIBLE UCITS ETF USD ACC | RVI EMERGENTES | 71,17% | · | · | · |
| NEUBERGER BERMAN NEXT GENERATION CONNECTIVITY SGD A ACC (HEDGED) | RVI TECNOLOGÍA | 71,15% | 185,93% | 105,46% | · |
| FIDELITY FUNDS-ASIAN SPECIAL SITUATIONS Y-ACC-USD | RVI ASIA EX-JAPÓN SMALL/MID CAP | 71,14% | 94,69% | 52,22% | 178,82% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I-H CAP EUR | RVI BIOTECNOLOGÍA | 71,10% | 80,80% | 59,85% | 171,97% |
